CLINICAL CASE OF OBSTETRIC ATYPICAL HEMOLYTIC UREMIC SYNDROME
Abstract
About the Authors
SVETLANA CH. Kara-SalRussian Federation
VADIM G. Mozes
Russian Federation
KIRA B. Mozes
Russian Federation
ELENA V. Rudaeva
Russian Federation
IGOR S. Zakharov
Russian Federation
SVETLANA I. Yelgina
Russian Federation
References
1. Nester CM, Thomas CP. Atypical hemolytic uremic syndrome: what is this, how is it diagnosed, and how is it treated? Hematology Am Soc Hematol Educ Program. 2012; 2012: 617-625. doi: 10.1182/asheducation-2012.1.617
2. Meri S. Complement activation in deseases presenting with thrombotic microangiopathy. Eur J Intern Med. 2013; 24 (6): 496-502. doi: 10.1016/j.ejim.2013.05.009
3. Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyó JM, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2013; 33 (1): 27-45. doi: 10.3265/Nefrologia.pre2012.Nov.11781
4. Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical haemolytic uraemic syndrome. N Engl J Med. 2013; 368 (23): 2169-2181. doi: 10.1056/NEJMoa1208981
Review
For citations:
Kara-Sal S.Ch., Mozes V.G., Mozes K.B., Rudaeva E.V., Zakharov I.S., Yelgina S.I. CLINICAL CASE OF OBSTETRIC ATYPICAL HEMOLYTIC UREMIC SYNDROME. Fundamental and Clinical Medicine. 2019;4(1):91-99. (In Russ.)